Managers' Decisions About Informal Accommodation Requests by Employees With and Without Disabilities
ABSTRACT Although formal accommodations are required by law across many jurisdictions, many employees seek informal adjustments to their work conditions. These individualized work arrangements are not rooted in legal compliance but are instead provided at managers' discretion.
Silvia Bonaccio +3 more
wiley +1 more source
The 2025 Centers for Disease Control and Prevention Nonoccupational HIV Postexposure Prophylaxis Guidelines: Updated Regimens and Remaining Questions. [PDF]
Allan-Blitz LT, Mayer KH.
europepmc +1 more source
Исследование работы горелки BIC–100 методом компьютерного моделирования
В. В. Климов +1 more
openalex +1 more source
Benthic Incubation Chamber (BIC) for in-situ assessment of primary productivity in different canopy-forming communities [PDF]
Bianca Reis +6 more
openalex +1 more source
Signaling Effects of Women's Quotas: An Analysis of Workforce Perceptions and Reactions
ABSTRACT Women's quotas are widely used to promote gender equality in organizations, yet little is known about how the general workforce perceives and reacts to them. Drawing on signaling theory, we examine employees' awareness of women's quotas and how it influences their reactions.
Madleen Meier‐Barthold +1 more
wiley +1 more source
Discovering Serum Stable Protein-Protein Interaction Inhibitors with N‑Terminus-Capped Bicyclic Phage Libraries. [PDF]
Pinnette N +5 more
europepmc +1 more source
Intensity Correlation Measurement to Simulate Two-body BICs and Probe Nonlinear Discrete Breathers [PDF]
Trideb Shit +4 more
openalex +1 more source
What's New? Breast cancer is now the most common malignancy among women in sub‐Saharan Africa (SSA). Its impact on survivors’ quality of life and Global Health Status (GHS), however, remains inadequately studied in this setting. Here, using data from the African Breast Cancer‐Disparities in Outcomes (ABC‐DO) study, the authors examined GHS over time in
Shamsudeen Mohammed +10 more
wiley +1 more source
Long‐term benefit from adjuvant tamoxifen therapy for ER+ HER2− breast cancer by PR positivity
What's New? Tamoxifen is a cornerstone of endocrine therapy for estrogen receptor (ER)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer. Its long‐term benefits, however, may vary by progesterone receptor (PR) status. Here, using data from the Stockholm tamoxifen trials, the authors evaluated whether PR expression predicts
Anna E. Nordenskjöld +8 more
wiley +1 more source

